Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Ride the Tiger with CD -- Ignore unavailable to you. Want to Upgrade?

To: Terry Maloney who wrote (203561)	9/11/2011 5:37:59 AM
From: TheSlowLane	8 Recommendations Read Replies (1) \| Respond to of 313046

So...the guys who hit pause on npk.v under $6 and sold and are now watching from the sidelines as it hits $9...they should wait for the serious news...and re-buy it at $20? For even more safety, they could wait for positive results on the Cambridge Process but the premium for that is going to be a lot more than $20, imo. ;^)

To: Terry Maloney who wrote (203561)	9/11/2011 12:21:28 PM
From: pocotrader	4 Recommendations Read Replies (1) \| Respond to of 313046

The carrot caper is the only mistake NPK has made IMO, the NR was written so poorly that investors who hadn't done their homework panicked, NPK has the goods as far as TP is concerned, the big question is NPK a $15-$20 stock or a $50-$100 stock if the Cambridge Process works economically, if the CP works NPK immediately becomes a take over target, Vale would be the logical choice but imagine what would happen to POT's bottom line if they lost the whole Brazilian market and on top of that there are other countries where the CP could be applied.